iBio Inc. logo

iBio Inc.

IBIO | NASDAQ
Chart Builder DCF Calculator
$1.25
-$0.01 (-0.79%)
Sep 22, 2026, 11:11 AM ET · Market open

Market Data

Market Cap
$19.89M
Enterprise Value
$-65.95M
Beta
1.29
Average Volume
885.44K
Shares Outstanding (Diluted)
104.06M
Shares Change YoY
533.6%
Institutional Ownership
16.24%
Exchange
NASDAQ
ISIN
US4510337086

Price Performance

Price Change 1M
-12.5%
Price Change 3M
-23.6%
Price Change 6M
-42.2%
Price Change YTD
-37.6%
Price Change 1Y
55.4%
Price Change 3Y
-79.7%
Price Change 5Y
-99.8%
1M CAGR (ann.)
-10.6%
1Y CAGR (ann.)
44.8%
5Y CAGR (ann.)
-70.7%
All-Time CAGR
-36.5%

Valuation

PE Ratio
-3.82
Forward PE
N/A
PEG Ratio
-0.02
Forward PEG
-0.07
PS Ratio
198.95
Forward PS
795.80
PB Ratio
0.23
P/FCF Ratio
-0.84
P/Adj. FCF Ratio
-0.79
P/OCF Ratio
-5.73
EV/Sales
-659.46
EV/EBIT
2.00
EV/EBITDA
2.04
EV/FCF
2.77
Earnings Yield
-26.2%
FCF Yield
-119.6%
Adj. FCF Yield
-126.5%

Financial Health

Net Cash
$87.49M
Total Debt
$2.2M
Cash & Short-Term Investments
$56.4M
Total Assets
$99.11M
Current Ratio
7.85
Quick Ratio
7.85
Debt / Equity Ratio
0.03
Debt / EBITDA
-0.07
Debt / FCF
-0.09
OCF / Debt
-10.56
Interest Coverage
-663.04
Altman Z-Score
-4.39
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-35141.0%
EBITDA Margin
-32345.0%
Net Profit Margin
-33044.0%
FCF Margin
-23796.0%
Adj. FCF Margin
-25169.0%
SBC / Revenue
1373.0%
SBC Impact (per share)
-5.8%

Returns

Return on Assets
-33.3%
Return on Equity
-47.9%
Return on Invested Capital
-40.0%
Return on Capital Employed
-40.2%
Return on Tangible Assets
-34.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
-25.9%
Revenue CAGR 5Y
-46.9%
Revenue CAGR 10Y
-20.1%
EPS CAGR 3Y
122.4%
EPS CAGR 5Y
93.5%
EPS CAGR 10Y
23.7%
FCF CAGR 3Y
-13.0%
FCF CAGR 5Y
25.1%
FCF CAGR 10Y
-4.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
4
EPS Growth Next 3Y
-40.4%
Revenue Growth Next 3Y
-30.7%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.06
EPS Growth Est (next Q)
-45.5%
Revenue Est (next Q)
$20K
Revenue Growth Est (next Q)
-80.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$5
Price Target Upside
296.8%

Cash Flow

Operating Cash Flow
$-23.22M
Free Cash Flow
$-23.8M
Adj. Free Cash Flow
$-25.17M
FCF Per Share
-$0.23
OCF Per Share
-$0.22
OCF/S Ratio
-23218.0%

Income Statement

Revenue
$100K
Gross Profit
$100K
Operating Income
$-35.14M
EBITDA
$-32.35M
Net Income
$-33.04M
EPS (Diluted)
-$0.33
Revenue / Employee
$5K
Profit / Employee
$-1.65M
Employees
20

© 2026 bestshares.com. All rights reserved.